Xenogen Corporation
About:
Xenogen Corporation is an integrated system of instruments and equipment, software and reagents to academic and biopharmaceutical
Website: http://www.xenogen.com
Top Investors: Silicon Valley Bank, Charlesbank Capital Partners, SR One, Abingworth, Partners for Growth
Description:
Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen's VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.
$115M
Alameda, California, United States
1994-01-01
David Benaron
51-100
2005-10-19
Delisted
© 2025 bioDAO.ai